Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,049 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Design of a PROspective multi-national CLOTBUST collaboration on reperfusion therapies for stroke (CLOTBUST-PRO).
Saqqur M, Tsivgoulis G, Molina CA, Demchuk AM, Garami Z, Barreto A, Spengos K, Forteza A, Mikulik R, Sharma VK, Brunser A, Martinez P, Montaner J, Kohrmann M, Schellinger PD, Alexandrov AV; CLOTBUST-PRO Investigators. Saqqur M, et al. Among authors: martinez p. Int J Stroke. 2008 Feb;3(1):66-72. doi: 10.1111/j.1747-4949.2008.00167.x. Int J Stroke. 2008. PMID: 18705918
Closing the Sex-Based Differences in Stroke Care: Insights from a Large Telestroke Network on Treatment and Postacute Management.
Pérez-Sánchez S, Barragán-Prieto A, Loscertales JB, Cabezas Rodríguez JA, Zapata-Arriaza E, Amaya Pascasio L, Hermosín Gómez A, Gamero García MÁ, Galeano B, Fernández J, Pardo Galiana B, Domínguez Mayoral A, Ainz Gómez L, Fernández Navarro J, Del Toro C, Medina M, de Torres R, Baena P, Moniche F, Valverde Moyano R, Martínez P, González A, Montaner J. Pérez-Sánchez S, et al. Among authors: martinez p. Health Equity. 2024 May 10;8(1):301-306. doi: 10.1089/heq.2023.0175. eCollection 2024. Health Equity. 2024. PMID: 39011077 Free PMC article.
Resource use during systematic review production varies widely: a scoping review.
Nussbaumer-Streit B, Ellen M, Klerings I, Sfetcu R, Riva N, Mahmić-Kaknjo M, Poulentzas G, Martinez P, Baladia E, Ziganshina LE, Marqués ME, Aguilar L, Kassianos AP, Frampton G, Silva AG, Affengruber L, Spjker R, Thomas J, Berg RC, Kontogiani M, Sousa M, Kontogiorgis C, Gartlehner G; working group 3 in the EVBRES COST Action (https://evbres.eu). Nussbaumer-Streit B, et al. Among authors: martinez p. J Clin Epidemiol. 2021 Nov;139:287-296. doi: 10.1016/j.jclinepi.2021.05.019. Epub 2021 Jun 4. J Clin Epidemiol. 2021. PMID: 34091021 Free article. Review.
Pharmacokinetics of Tarlatamab, a Delta-Like Ligand-3 (DLL3) Targeted Half-Life Extended Bispecific T-Cell Engager (BiTE®) Immunotherapy in Adult Patients with Previously Treated Small-Cell Lung Cancer: Results from DeLLphi-300, a Phase I Multiple-Dose-Escalation Study.
Minocha M, Thompson CG, Murphy A, Zhou Y, Brandl C, Parkes A, Chen X, Yu B, Martinez P, Houk BE. Minocha M, et al. Among authors: martinez p. Clin Pharmacokinet. 2024 Nov 26. doi: 10.1007/s40262-024-01451-7. Online ahead of print. Clin Pharmacokinet. 2024. PMID: 39589690
Impact of universal use of the McGrath videolaryngoscope as the first option for all intubations in the operating room: The multicentre prospective before-after VIDEOLAR-SURGERY study protocol.
Taboada M, Estany-Gestal A, Rama-Maceiras P, Orallo MA, Bermúdez M, Barreiro C, Gómez L, Amor M, Otero F, Fernández J, Molins N, Amate JJ, Bascuas B, Rey R, Alonso MC, Castro MJ, Sarmiento A, Dos Santos L, Nieto C, Paredes S, Velasco A, Taboada C, Martín L, Campaña D, Mosquera E, Novoa C, Varela S, da Silva L, Domínguez E, Bedoya A, Gómez AI, Estévez M, Martínez P, Sotojove R, Naveiro A, Díaz C, Ruido R, Mirón P, González M, Francisco C, Regueira J, Peiteado M, Eiras M, Paz E. Taboada M, et al. Among authors: martinez p. Rev Esp Anestesiol Reanim (Engl Ed). 2024 Nov 12:101649. doi: 10.1016/j.redare.2024.101649. Online ahead of print. Rev Esp Anestesiol Reanim (Engl Ed). 2024. PMID: 39542091
Plain language summary: tarlatamab for patients with previously treated small cell lung cancer.
Ahn MJ, Cho BC, Felip E, Korantzis I, Ohashi K, Majem M, Juan-Vidal O, Handzhiev S, Izumi H, Lee JS, Dziadziuszko R, Wolf J, Blackhall F, Reck M, Alvarez JB, Hummel HD, Dingemans AC, Sands J, Akamatsu H, Owonikoko TK, Ramalingam SS, Borghaei H, Johnson ML, Huang S, Mukherjee S, Minocha M, Jiang T, Martinez P, Anderson ES, Paz-Ares L. Ahn MJ, et al. Among authors: martinez p. Future Oncol. 2024 Nov 12:1-10. doi: 10.1080/14796694.2024.2402152. Online ahead of print. Future Oncol. 2024. PMID: 39530627
2,049 results